Report copyright - The Epicutaneous Immunotherapy Company - Jefferies...DBV Technologies Today Recent Progress 3 Viaskin Peanut –Phase III data expected in 2H 2017―Pivotal Phase III recruitment completed
Please pass captcha verification before submit form